Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer-Reference-Cited by-同舟云学术

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer

Published:2014-04-22 Issue:7 Volume:15 Page:826-831
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Capalbo Carlo,Marchetti Paolo,Coppa Anna,Calogero Antonella,Anastasi Emanuela,Buffone Amelia,Belardinilli Francesca,Gulino Matteo,Frati Paola,Catalano Carlo,Cortesi Enrico,Giannini Giuseppe,Gulino Alberto

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.28878

Reference30 articles.

1. The role of personalized medicine in metastatic colorectal cancer: an evolving landscape

2. Current opinion on optimal treatment for colorectal cancer

3. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

4. Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer

5. KRAS and Colorectal Cancer: Ethical and Pragmatic Issues in Effecting Real-Time Change in Oncology Clinical Trials and Practice

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond;World Journal of Gastroenterology;2023-03-07

2. Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer;Frontiers in Oncology;2020-05-07

3. Improvements in Clinical Outcomes for BRAFV600E-Mutant Metastatic Colorectal Cancer;Clinical Cancer Research;2020-04-06

4. BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors;BMC Cancer;2020-02-17

5. Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico Models;Cancers;2019-12-20